Comment on "Adjuvant therapy in pancreatic cancer: A critical appraisal"

Drugs

Volumn 67, Issue 17, 2007, Pages 2481-2485

  Abrams, Ross A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fluorouracil, therapeutic use; Gemcitabine, therapeutic use; Pancreatic cancer, treatment

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FOLLOW UP; HUMAN; NONHUMAN; NOTE; OVERALL SURVIVAL; PANCREAS CANCER;

EID: 36349000521     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767170-00001     Document Type: Note

References (36)

1. Oettle H, Neuhaus P. Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 2007; 67 (16): 2293-310
2. Neoptolemos J, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in respectable pancreatic cancer: a randomized controlled trial. Lancet 2001; 358: 1576-85
3. Abrams RA, Lillemoe KD, Piantadosi S. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet 2001; 358: 1565-6
4. Neoptolemos J, Stocken D, Friess H, et al. A randomized trial of chemoradiotheapy and chemotherapy after resection of pancreatic cancer. New Engl J Med 2004; 350: 1200-8
5. Abrams RA, Yeo CJ. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinomas: a review of studies and experience at the Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am 2004; 13: 621-38
6. Dickler A, Abrams RA. Radiochemotherapy in the management of pancreatic cancer. Part II: use in adjuvant and locally unresectable settings. Semin Radiat Oncol 2005; 15: 235-44
7. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903
8. Baakevold KE, Arnesjo B, Dahl O, et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater: results of a controlled, prospective, randomized multicentre study. Eur J Cancer 1992; 29: 689-703
9. Klinkenbijl J, Jeekel J, Sahmound T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230: 776-84
10. Regine WF, Abrams R. Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys 1998; 42: 59-63
11. Abrams RA, Winter KA, Regine WF, et al. RTOG 9704: radiotherapy quality assurance (QA) review and survival. Int J Radiat Oncol Biol Phys 2006; 66 Suppl. 3: S22
12. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative intent resection of pancreatic cancer: a multicenter randomized controlled trial. JAMA 2007; 297: 267-77
13. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single institution experience. Ann Surg 1997; 225: 621-36
14. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic adenocarcinomas. Cancer 1990; 66: 56-61
15. Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm: general principles. Nat Clin Pract Oncol 2007 Feb; 4 (2): 86-100
16. Kelsen D. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer. Semin Oncol 1994 Aug; 21 (4 Suppl. 7): 58-66
17. Lidestahl A, Permert J, Linder S, et al. Efficacy of systemic therapy in advanced pancreatic carcinoma. Acta Oncol 2006; 45 (2): 136-43
18. Xiong HQ, Carr K, Abbruzzese JL. Cytotoxic chemotherapy for pancreatic cancer: advances to date and future directions. Drugs 2006; 66 (8): 1059-72
19. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12
20. Ferrone CR, Finkelstein DM, Thayer SP. Perioperative CA19-9 levels can predict stage and survivalin patients with resectable pancreatic adenocarcinoma. J Clin Oncol 2006; 24: 2897-902
21. Boeck S, Stieber P, Holdenrieder S, et al. Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology 2006; 70: 255-64
22. Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004; 240: 293-8
23. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002 Apr 11; 346 (15): 1128-37
24. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-27
25. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004; 198: 722-31
26. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995 Jun; 221 (6): 721-31
27. Heidelberger C, Griesbach L, Montag BJ, et al. Studies on fluorinated pyrmidines II: effects on transplanted tumors. Cancer Res 1958; 18: 305-17
28. Moertel CG, Frytak S, Hang RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil) and high dose radiation + 5-fluorouracil. Cancer 1981; 48: 1705-10
29. Moertel CG, Childs Jr DS, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969 Oct 25; II (7626): 865-7
30. Childs DS, Moertel CG, Holbrook MA, et al. Treatment of malignant neoplasms of the gastrointestinal tract with a combination of 5-fluorouracil and radiation: a randomized double-blind study. Radiology 1965; 84: 843-8
31. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Nat Cancer Inst 1988; 80: 751-5
32. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 1997; 337 (14): 956-62
33. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who received chemotherapy. N Engl J Med 1997; 337 (14): 949-55
34. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-6
35. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992; 10: 890-5
36. Pignon JP, Arriagada R, Ihde DC, et al. A metaanalysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992; 327: 1618-24